Lentiviral Vector Platform for Production of Bioengineered Recombinant Coagulation Factor VIII-Reference-Cited by-同舟云学术

Lentiviral Vector Platform for Production of Bioengineered Recombinant Coagulation Factor VIII

Published:2011-02 Issue:2 Volume:19 Page:302-309
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Spencer H Trent,Denning Gabriela,Gautney Richard E,Dropulic Boro,Roy Andre J,Baranyi Lajos,Gangadharan Bagirath,Parker Ernest T,Lollar Pete,Doering Christopher B

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference21 articles.

1. rFactor VIII deficit questioned;Garber;Nat Biotechnol,2000

2. Biosynthesis, assembly and secretion of coagulation factor VIII;Kaufman;Blood Coagul Fibrinolysis,1997

3. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII;Swaroop;J Biol Chem,1997

4. Bioengineering of coagulation factor VIII for improved secretion;Miao;Blood,2004

5. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A;Doering;Mol Ther,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor;Blood Journal;2023-05-16

2. Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII;Frontiers in Immunology;2022-12-15

3. Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII;International Journal of Hematology;2022-10-14

4. Structural insights into blood coagulation factor VIII: Procoagulant complexes, membrane binding, and antibody inhibition;Journal of Thrombosis and Haemostasis;2022-09

5. Recombinant Expression of Complex Proteins in Human Cell Lines;Methods in Molecular Biology;2022